NCT00267085
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +14 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
194 public trials
80 recruiting studies
Neoplasm, Residual trial results
NCT00358072
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Ospedali Riuniti di Bergamo Bergamo, BG, Italy
- Divisione Ematologia Spedali Civili Brescia, BS, Italy
- Divisione di Ematologia e TMO Ospedale San Maurizio Bolzano, BZ, Italy
- U.O. Ematologia e Centro TMO Ospedale Armando Businco Cagliari, CA, Italy
NCT00199004
- Conditions
- Adult Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany
Active, Not Recruiting
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
NCT01059786
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
NCT03516279
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Elimination of Minimal Residual Disease After Transplant
NCT05690984
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Active, Not Recruiting
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
- Locations
-
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Active, Not Recruiting
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT02724163
- Conditions
- Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Women and Children's Hospital Adelaide Adelaide, Australia
- Queensland Children's Hospital Brisbane, Australia
- Monash Children's Hospital Melbourne, Australia
- Royal Childrens Hospital Melbourne, Australia
Active, Not Recruiting
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
NCT03876769
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- Children s Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- City of Hope National Medical Duarte, California, United States
- Childrens Hospital Los Angeles Los Angeles, California, United States
Active, Not Recruiting
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
NCT03945721
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +10 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States